• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Indexing powder patterns in physical form screening: instrumentation and data quality.

作者信息

Florence Alastair J, Baumgartner Bruno, Weston Chris, Shankland Norman, Kennedy Alan R, Shankland Kenneth, David William I F

机构信息

Department of Pharmaceutical Sciences, University of Strathclyde, Glasgow G4 0NR, UK.

出版信息

J Pharm Sci. 2003 Sep;92(9):1930-8. doi: 10.1002/jps.10459.

DOI:10.1002/jps.10459
PMID:12950010
Abstract

Two multisample laboratory powder diffractometers have been evaluated for the purpose of pattern indexing in the context of physical form screening. Both diffractometers utilise foil transmission geometry, primary monochromated radiation, and a position-sensitive detector. Data collected from six compounds (sotalol hydrochloride, hydroflumethiazide, verapamil hydrochloride, captopril, clomipramine hydrochloride, and famotidine) showed good angular resolution (FWHM as small as ca. 0.06 degrees ) and lattice parameters were easily obtained using the indexing program DICVOL-91. The extent of preferred orientation in each pattern was estimated using the DASH implementation of the March-Dollase function and is most evident with clomipramine hydrochloride and famotidine. Otherwise, the data compare favorably with reference capillary data sets. In conclusion, where there is a requirement to analyze 20-30 samples per day, with an emphasis on obtaining the high-quality data that are important in pattern recognition and imperative in indexing, the combination of foil transmission geometry, primary monochromated radiation, plus a position-sensitive detector is highly effective. The data also afford opportunities for crystal structure determination.

摘要

相似文献

1
Indexing powder patterns in physical form screening: instrumentation and data quality.
J Pharm Sci. 2003 Sep;92(9):1930-8. doi: 10.1002/jps.10459.
2
The determination of crystal structures of active pharmaceutical ingredients from X-ray powder diffraction data: a brief, practical introduction, with fexofenadine hydrochloride as example.从X射线粉末衍射数据确定活性药物成分的晶体结构:以盐酸非索非那定为例的简要实用介绍。
J Pharm Pharmacol. 2015 Jun;67(6):773-81. doi: 10.1111/jphp.12374. Epub 2015 Feb 10.
3
Pushing the Limits of Molecular Crystal Structure Determination From Powder Diffraction Data in High-Throughput Chemical Environments.在高通量化学环境中从粉末衍射数据中推动分子晶体结构测定的极限。
J Pharm Sci. 2018 Aug;107(8):2042-2047. doi: 10.1016/j.xphs.2018.04.010. Epub 2018 Apr 18.
4
Application of molecular replacement to protein powder data from image plates.分子置换法在来自图像板的蛋白质粉末数据中的应用。
Acta Crystallogr D Biol Crystallogr. 2009 Apr;65(Pt 4):348-55. doi: 10.1107/S0907444909003783. Epub 2009 Mar 19.
5
A quick method for the quantitative analysis of mixtures. 1. Powder X-ray diffraction.
J Pharm Sci. 2008 Jun;97(6):2260-76. doi: 10.1002/jps.21142.
6
Structure determination from conventional powder diffraction data: application to hydrates, hydrochloride salts, and metastable polymorphs.从常规粉末衍射数据确定结构:在水合物、盐酸盐和亚稳多晶型物中的应用。
J Pharm Sci. 2000 Jul;89(7):958-66. doi: 10.1002/1520-6017(200007)89:7<958::AID-JPS14>3.0.CO;2-S.
7
Powder diffraction crystallography of molecular solids.分子固体的粉末衍射晶体学
Top Curr Chem. 2012;315:133-77. doi: 10.1007/128_2011_251.
8
Differential evolution: crystal structure determination of a triclinic polymorph of adipamide from powder diffraction data.
Chem Commun (Camb). 2002 Apr 21(8):880-1. doi: 10.1039/b200436d.
9
Quantification of crystalline forms in active pharmaceutical ingredient and tablets by X-ray powder diffraction.采用X射线粉末衍射法对活性药物成分及片剂中的晶型进行定量分析。
J Pharm Pharmacol. 2003 Sep;55(9):1323-9. doi: 10.1211/0022357021675.
10
Application of powder X-ray diffraction in studying the compaction behavior of bulk pharmaceutical powders.粉末X射线衍射在研究原料药粉末压实行为中的应用。
J Pharm Sci. 2005 Nov;94(11):2520-30. doi: 10.1002/jps.20415.

引用本文的文献

1
Crystal structure of the co-crystal butyl-paraben-isonicotinamide (1/1).对羟基苯甲酸丁酯-异烟酰胺共晶体(1/1)的晶体结构
Acta Crystallogr E Crystallogr Commun. 2016 Jan 1;72(Pt 1):53-5. doi: 10.1107/S2056989015023518.
2
Crystal structure of a mixed solvated form of amoxapine acetate.醋酸阿莫沙平混合溶剂化物的晶体结构
Acta Crystallogr E Crystallogr Commun. 2015 Jan 10;71(Pt 2):139-41. doi: 10.1107/S2056989014028096. eCollection 2015 Feb 1.
3
Validation of molecular crystal structures from powder diffraction data with dispersion-corrected density functional theory (DFT-D).
利用色散校正密度泛函理论(DFT-D)从粉末衍射数据验证分子晶体结构。
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2014 Dec;70(Pt 6):1020-32. doi: 10.1107/S2052520614022902. Epub 2014 Dec 1.
4
2-Methyl-4-(4-methyl-piperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine (olanzapine) propan-2-ol disolvate.2-甲基-4-(4-甲基哌嗪-1-基)-10H-噻吩并[2,3-b][1,5]苯二氮䓬(奥氮平)异丙醇二溶剂化物
Acta Crystallogr Sect E Struct Rep Online. 2013 Apr 20;69(Pt 5):o752-3. doi: 10.1107/S1600536813009811. Print 2013 May 1.
5
6-Methyl-1,3,5-triazine-2,4-diamine butane-1,4-diol monosolvate.6-甲基-1,3,5-三嗪-2,4-二胺丁烷-1,4-二醇单溶剂合物
Acta Crystallogr Sect E Struct Rep Online. 2012 Dec 1;68(Pt 12):o3377. doi: 10.1107/S1600536812044480. Epub 2012 Nov 17.
6
Nicotinamide-2,2,2-trifluoro-ethanol (2/1).烟酰胺 - 2,2,2 - 三氟乙醇(2/1)
Acta Crystallogr Sect E Struct Rep Online. 2009 Mar 11;65(Pt 4):o727-8. doi: 10.1107/S1600536809007594.
7
3-Amino-carbonyl-pyridinium difluoro-acetate at 123 K.123K下的3-氨基甲酰基吡啶二氟乙酸盐。
Acta Crystallogr Sect E Struct Rep Online. 2009 Oct 28;65(Pt 11):o2896-7. doi: 10.1107/S1600536809043414.
8
Cytenamide-formic acid (1/1).胞嘧啶酰胺-甲酸(1/1)
Acta Crystallogr Sect E Struct Rep Online. 2008 Jul 5;64(Pt 8):o1379-80. doi: 10.1107/S1600536808019181.
9
Cytenamide-1,4-dioxane (2/1).胞嘧啶酰胺 - 1,4 - 二氧六环(2/1)
Acta Crystallogr Sect E Struct Rep Online. 2008 Jun 28;64(Pt 7):o1345-6. doi: 10.1107/S1600536808018709.
10
Cytenamide-butyric acid (1/1).胞嘧啶酰胺丁酸(1/1)
Acta Crystallogr Sect E Struct Rep Online. 2008 Jun 19;64(Pt 7):o1295-6. doi: 10.1107/S1600536808018059.